Curated News: Medical Meetings

• share
• favorite_border

Weight-loss surgery improves or resolves diseases including type 2 diabetes, heart disease and high blood pressure and can lead to significant and durable weight loss for many people, but the operation has largely been restricted to those with severe obesity, which means about 75 to 100 pounds overweight or a body mass index (BMI) of 35 or higher with an obesity-related disease.

• share
• favorite_border

A new study released today finds residents in several states with the highest obesity rates in the country are among the least likely to undergo weight-loss surgery, long considered the standard of care for severe obesity and related diseases including type 2 diabetes and heart disease.

• share
• favorite_border

The risk of stroke is cut by more than half in what researchers believe is the largest patient sample size ever for a study on bariatric surgery and its effect on ischemic cerebrovascular disease (96,094 bariatric surgery patients and 1,533,725 matched nonsurgical patients with obesity).

• share
• favorite_border

Long-Term Outcomes of Duodenal Switch (DS) Versus Single Anastomosis Duodeno-Ileostomy with Sleeve Gastrectomy (SADI-S): A Matched Cohort Study

• share
• favorite_border

New findings include a significant increase in risk of death among patients who had recently had chemotherapy.

• share
• favorite_border

Evidence suggests auditory and vestibular effects should be added to the growing list of physiological impacts of COVID-19. During the 180th Meeting, Colleen Le Prell from the University of Texas at Dallas will talk about hearing and balance disorders associated with coronavirus infection and how pandemic-related stress and anxiety may aggravate tinnitus symptoms. Her presentation, "Hearing disorders secondary to infection with SARS-CoV-2," will take place Thursday, June 10.

• share
• favorite_border

As more people are taking advantage of music on the go, personal audio systems are pumping up the volume to the detriment of the listener's hearing. During the 180th ASA Meeting, Daniel Fink from The Quiet Coalition and Jan Mayes will talk about current research into personal audio system usage and the need for public health hearing conservation policies. Their session, "Personal audio system use can harm auditory health," will take place Thursday, June 10.

• share
• favorite_border

New collaborative research shows that treatment with immune checkpoint inhibitors (ICIs) has led to a significant improvement in survival and response rates among patients with a particularly aggressive type of kidney cancer: advanced sarcomatoid renal cell carcinoma. The study, which was led by a team from Roswell Park Comprehensive Cancer Center and involved contributors from six centers, is detailed in a presentation at the American Society of Clinical Oncology 2021 virtual annual meeting (abstract 4568).

• share
• favorite_border

Researchers at Roswell Park Comprehensive Cancer Center led the largest study to date to suggest an improving trend in pathologic complete response rates over time for U.S. cancer patients of various races. The team's findings, documented in a poster presentation at the 2021 American Society of Clinical Oncology virtual annual meeting (abstract 575), show that African Americans are more likely than patients from any other group to have remaining disease following breast cancer treatment.

• share
• favorite_border

New work from a team at Roswell Park Comprehensive Cancer Center will help guide the care of patients with neuroendocrine tumors, or NETs. In a poster presentation at the American Society of Clinical Oncology (ASCO) virtual Annual Meeting 2021, Abhay Singh, MD, MPH, and colleagues outline their discovery of a potential biomarker to predict which patients are likely to experience blood toxicity side effects from a new targeted radiation treatment, peptide receptor radionuclide therapy (PRRT).

• share
• favorite_border

Designing a soundscape to improve quality of life for an individual is centered on putting their perception at the heart of the process. During the 180th ASA Meeting, Arezoo Talebzadeh from Ghent University will show how a personalized soundscape can help those with dementia by providing clues regarding time of day and place. The session, "Soundscape design for people with dementia; the correlation between psychoacoustic parameter and human perception," will take place Wednesday, June 9.

• share
• favorite_border

According to the World Health Organization, more than 264 million people worldwide have Major Depression Disorder and another 20 million have schizophrenia. During the 180th ASA Meeting, Carol Espy-Wilson from the University of Maryland,will discuss how a person's mental health status is reflected in the coordination of speech gestures. The keynote lecture, "Speech Acoustics and Mental Health Assessment," will take place Tuesday, June 8.

• share
• favorite_border

Variations in children's speech has traditionally been attributed to developmental delays. Recent work suggests the reasons for variability are not so clear, and an immediate call for treatment may need to be reconsidered. During the 180th ASA Meeting, Margaret Cychosz from the University of Maryland will discuss the need to better understand these variations. Her presentation, "Reconsidering variability in child speech production," will take place Tuesday, June 8.

• share
• favorite_border

Atlantic Health System Cancer Care physicians are lead or co-authors of seven original studies to be presented and published at the 2021 ASCO Annual Meeting, held virtually June 4-8. The ASCO annual meeting is the world’s leading venue for presenting original clinical research on cancer.

• share
• favorite_border

As COVID-19 spread throughout the world, our daily routines and behaviors changed drastically. A new study of more than 2,000 people in the U.S. found that the pandemic has also affected how we eat. The authors found a decrease in the consumption of many food groups, particularly healthy foods such as vegetables and whole grains, compared to before the pandemic.

• share
• favorite_border

Reducing food waste is crucial to our ability to feed the growing human population but will not fully solve the problem alone, according to a new study based on a computational model.

• share
• favorite_border

According to a new study, people who eat faster or take larger bites are more likely to eat more at a meal. The research, which is being presented at NUTRITION 2021 LIVE ONLINE, provides new insight into the factors that might contribute to overeating.

• share
• favorite_border

A new study of more than 350,000 women found that women with diets incorporating more foods that increase inflammation in the body had a 12% increase in their risk of breast cancer compared to women who consume more anti-inflammatory diets.

• share
• favorite_border

There has been a long-standing debate as to whether a low-fat or a plant-centered diet is better at lowering the risk of cardiovascular disease. A new study that followed more than 4,700 people over 30 years, found that a plant-centered diet was associated with a lower long-term risk for cardiovascular disease. However, both diets were linked with lower LDL, or bad cholesterol, levels.

• share
• favorite_border

Only 5% of men and 9% of women are getting the recommended daily amount of dietary fiber, according to a study being presented at NUTRITION 2021 LIVE ONLINE. Insufficient fiber intake is associated with a higher risk of heart disease and diabetes, two of the most common diseases in the U.S.

• share
• favorite_border

According to a new study, adults overall ate more refined grains and solid fats and children increased their intake of added sugar during the recession. The impacts of the downturn were especially pronounced in food-insecure households, where individuals significantly reduced their intake of protein and dark green vegetables while increasing total sugars.

• share
• favorite_border

Studies being presented at NUTRITION 2021 LIVE ONLINE bring new insights into how people ate, shopped and felt about food as the COVID-19 pandemic unfolded. Studying these trends can shed light on potential lingering health impacts of the pandemic and inform responses to future emergencies.

• share
• favorite_border

What we eat during childhood can affect the health of individuals—and populations—for years to come. As rates of childhood obesity continue to rise, five studies being presented at NUTRITION 2021 LIVE ONLINE bring new insights into the diets of children and teens around the world.

• share
• favorite_border

Superfoods like turmeric and honey have long been recognized for their ability to promote health and wellness. New studies being presented at NUTRITION 2021 LIVE ONLINE take a closer look at the science behind the health benefits of superfoods.

• share
• favorite_border

Healthy habits are particularly important during pregnancy. Four new studies being presented at NUTRITION 2021 LIVE ONLINE look at how supplements, eating habits and physical activity can affect various aspects of health during pregnancy.

• share
• favorite_border

Even moderate smartphone use may influence teens’ diet and weight, according to a new study of more than 53,000 Korean adolescents. Teens who used a smartphone for more than 2 hours per day were significantly more likely to eat more junk food and fewer fruits and vegetables than those spending less time on their phone. Teens spending more than 3 hours per day on a smartphone were significantly more likely to be overweight or obese.

• share
• favorite_border

A pain-management protocol designed by Emese Zsiros, MD, PhD, FACOG, to be reported at the American Society of Clinical Oncology 2021 annual meeting, resulted in a 45% decrease in opioids prescribed to patients undergoing surgery, without significant effect on recovery or satisfaction.

• share
• favorite_border

The Roswell Park Comprehensive Cancer Center/Kaiser Permanente Northern California team behind a new study to be highlighted at the ASCO 2021 virtual annual meeting has found that sufficient vitamin D levels at the time of diagnosis are associated with improved outcomes among people with breast cancer.

• share
• favorite_border

Innovative research refines the treatment of patients with advanced cancers and the use of immunotherapy

• share
• favorite_border

The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial led by Washington University School of Medicine in St. Louis. The drug is designed to shut down the effects of the mutation, which is found in about 13% of patients with lung adenocarcinoma, a common type of non-small-cell lung cancer.

• share
• favorite_border

Results from the Phase II cohort of the CodeBreaK 100 study showed that treatment with the KRAS G12C inhibitor sotorasib achieved 12.5 months median overall survival in previously treated patients with KRAS G12C-mutated non-small cell lung cancer, according to researchers from The University of Texas MD Anderson Cancer Center.

• share
• favorite_border

ROCHESTER, Minn. — A study by researchers at Mayo Clinic Cancer Center has found that cancer patients diagnosed with COVID-19 who received care at home via remote patient monitoring were significantly less likely to require hospitalization for their illness, compared to cancer patients with COVID-19 who did not participate in the program. Results of the study were presented Friday, June 4, at the American Society of Clinical Oncology Annual Meeting and published in the Journal of Clinical Oncology.

• share
• favorite_border

At the American Society of Clinical Oncology 2021 virtual Annual Meeting, Roswell Park teams will share data and insights on topics ranging from reducing use of opioids to an analysis of trends in response to cancer treatment among patients of different races.

• share
• favorite_border

New data from researchers at Memorial Sloan Kettering Cancer Center (MSK) featured in the 2021 ASCO Annual Meeting press program highlights a promising new treatment option for individuals previously treated for metastatic castration-resistant prostate cancer (mCRPC).

• share
• favorite_border

Treatment with an immunotherapy drug following kidney cancer surgery, prolonged disease-free survival rates in patients at high risk for recurrence, according to an interim report of a phase 3 clinical trial of adjuvant immunotherapy in this patient population.

• share
• favorite_border

ACSM's comprehensive sports medicine and exercise science conference takes place virtually from June 1 to 5 with programming covering the science, practice, public health and policy aspects of sports medicine, exercise science and physical activity.

• share
• favorite_border

A treatment regimen for patients with advanced melanoma that combines the immunotherapy agents relatlimab (anti-LAG-3) and nivolumab (anti-PD-1) delayed time to cancer progression significantly more than nivolumab alone, according to results of a study to be presented June 6 at the 2021 American Society of Clinical Oncology (ASCO) annual meeting.

• share
• favorite_border

• share
• favorite_border

Moffitt Cancer Center, a national leader in cancer care and research and the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, is presenting new data from dozens of clinical research studies at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting, the world’s largest clinical cancer research meeting. Moffitt investigators will lead 25 abstract presentations, five education sessions, two cancer-based panels and two clinical science symposia. The virtual meeting is June 4-8.

• share
• favorite_border

Press materials are now available for NUTRITION 2021 LIVE ONLINE, a dynamic virtual event showcasing new research findings and timely discussions on food and nutrition. The online meeting will be held June 7–10, 2021.

• share
• favorite_border

An odor-based test that sniffs out vapors emanating from blood samples was able to distinguish between benign and pancreatic and ovarian cancer cells with up to 95 percent accuracy.

• share
• favorite_border

In the longest follow-up results from a clinical trial of combination immunotherapy for metastatic melanoma, investigators report that nearly half the patients who received the drugs nivolumab and ipilimumab were alive a median of six and a half years after treatment.

• share
• favorite_border

Dr. Kenneth Wells, UCLA Fielding School of Public Health professor of health policy and management, will collaborate with colleagues at UCLA and the Department of Veteran’s Affairs to lead this week’s “Veteran Resilience and Recovery” conference at UCLA, created to focus on the veteran community, including addressing homelessness and behavioral health.

• share
• favorite_border

Several Phase II clinical trials conducted by researchers from The University of Texas MD Anderson Cancer Center show promising results for patients with melanoma, breast cancer, HER2-positive tumors and ovarian cancer. The results of these studies, which will be presented at the virtual 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, highlight new advances in drug therapy research to improve patient outcomes.

• share
• favorite_border

Dynamic science meeting to address critical food safety, nutrition topics

• share
• favorite_border

ISPOR announced its upcoming ISPOR Summit 2021: Value Assessment that will be held on June 10.

• share
• favorite_border

• share
• favorite_border

A combination of ponatinib and blinatumomab was found to be safe and highly effective in patients with newly diagnosed or relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL), according to researchers at The University of Texas MD Anderson Cancer Center. The study may support a regimen to produce complete remission with front-line therapy, without the increased risks associated with systemic chemotherapy or a stem cell transplant.

• share
• favorite_border

Cancer drugs capable of weakening the body’s immune defenses are no more likely to increase the risk of Covid-19 infection or death than breast cancer therapies that do not undermine the immune system, a new study shows.